Pradžia › Limfoma › Texas › Dallas

Limfoma klinikiniai tyrimai Dallas, TX

10 tyrimai dėl Limfoma ieško dalyvių vietose Dallas ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Renkami dalyviai1/2 fazė

Baylor Scott & White Research Institute, Texas Oncology, Dallas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-10-01 · NCT06343311

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Renkami dalyviai1/2 fazė

The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas

Iki 25 metų · Visoms lytims · Atnaujinta 2026-09-25 · NCT04094610

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Renkami dalyviai1/2 fazė

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

12 Months – 21 Years · Visoms lytims · Atnaujinta 2026-09-11 · NCT04870944

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Renkami dalyviai1/2 fazė

Baylor Scott & White Health, Dallas

Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT04588922

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Renkami dalyviai1/2 fazė

Baylor University Medical Center, Dallas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT05826535

DALY II USA/ MB-CART2019.1 for DLBCL

Renkami dalyviai2 fazė

UT Southwestern Medical Center, Dallas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT04792489

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Renkami dalyviai1/2 fazė

Call for Information (Investigational Site 0054), Dallas

6 Months – 17 Years · Visoms lytims · Atnaujinta 2026-07-06 · NCT02332668

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Renkami dalyviaiStebimasis tyrimas

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Visi amžiai · Visoms lytims · Atnaujinta 2026-05-18 · NCT01790152

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Renkami dalyviai1/2 fazė

University of Texas(UT) Southwestern-Children's Medical Center, Dallas

Amžius nuo 12 iki 95 · Visoms lytims · Atnaujinta 2026-04-15 · NCT04329728

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Renkami dalyviai1 fazė

UT Southwestern Medical Center, Dallas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-04 · NCT05892718

Limfoma tyrimai kituose miestuose

Kiti tyrimai Dallas

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.